Condition
Obesity and Metabolic Syndrome
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownComparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTsNCT07589322 · 2026-03-31
RECRUITINGAuricular Acupressure Integrated With a Smartphone Application for Weight ReductionNCT06744933 · 2025-04-09
NOT_YET_RECRUITINGThe Effects of Early vs. Delayed Time-Restricted Eating on Metabolic Syndrome ParametersNCT07096505 · 2023-07-21
COMPLETEDInflammatory and Metabolic Outcomes After Obese Woman Performed High Intensity Interval TrainingNCT03409172 · 2016-06-01
COMPLETEDCommon interventions
Control group with calorie restrictionBEHAVIORAL1CTROTHER1Delayed Time Restricted Eating with calorie restrictionBEHAVIORAL1Early time restricted eating with calorie restrictionBEHAVIORAL1HIITOTHER1MICTOTHER1Self-administered auricular acupressure integrated with a smartphone applicationCOMBINATION_PRODUCT1Semaglutide with lifestyle modificationDRUG1Tirzepatide with lifestyle modificationDRUG1
Leading sponsors
Trial status mix
COMPLETED2
NOT_YET_RECRUITING1
RECRUITING1
Phase mix
NA4
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.